3544 POSTER Phase I study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy in gemcitabine-refractory pancreatic cancer patients.
暂无分享,去创建一个
H. Ueno | J. Furuse | M. Ikeda | T. Okusaka | E. Suzuki | T. Ogura | C. Morizane | K. Nakachi | H. Ishii | Masataka Ikeda | Hikaru Ueno | Masataka Ikeda